Question 38698 — pharmacy and medications

Summary

Ms. Catherine Fabre questions the Minister of Solidarity and Health on equitable access for hospitalized patients to innovative health treatments. Indeed, according to the Institut Montaigne report “Innovative medicines: prevention for better cure” published in September 2019, new innovative medicines require very significant research and development costs and are accessible to few patients, which poses challenges. questions of budgetary sustainability as well as access to these treatments for all patients. Some of them can be reimbursed at 100% of the prescription of an innovative medical treatment, in accordance with the additional lists tested since 2018. However, the benefit of this coverage by health insurance is very heterogeneous depending on the budgetary decisions of each health establishment, which does not allow equitable access for patients to innovative medicines in the territories. Therefore, she would like to know the Minister's position on access to these innovative health devices, and to know if he is in favor of relaxing the criteria for including innovative medicines on the list in addition in order to avoid any risk of unequal treatment or loss of opportunities for patients.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.